Reference no: EM132333876 , Length: word count:3500
Management of Chronic Disease (Singapore) Assignment - Portfolio Of Evidence
Introduction - The purpose of this educational portfolio is to enable you to identify and achieve the prescribed learning outcomes within the overall context of NUR09721 - Management of Chronic Disease (Singapore).
Learning Outcomes - The learning outcomes are as follows:
1: Evaluate the evidence-base underpinning current practice in the management of people affected by chronic diseases.
2: Examine the social and psychological impact of conclusive diagnosis of a chronic disease on people and their family/ carers.
3: Explore the role of the multidisciplinary team in promoting self-management to enable people to live positively with a chronic disease.
4: Analyse current local practice and identify possible changes to improve psychological symptoms and health, and well-being for people living with one or more chronic diseases.
You will be required to provide evidence of achievement for each learning outcome within your portfolio.
Management of chronic Disease Assessment -
Introduction - Briefly introduce your allocated condition in your introduction. This should include a definition of what a long-term condition is and an explanation of your allocated condition along with a brief overview of its epidemiology and aetiology. The introduction must also outline how you searched for academic evidence to support this portfolio to answer the learning outcomes for this assessment (500 words).
A search strategy outlining the relevant search terms you used, the research databases you searched and the number and type of results you obtained should be provided. This can be given in a table format to ensure you stay within the word count for this section.
Portfolio Entry 1 - Describe the pathophysiology of the allocated condition, supported by relevant academic literature. (500 words)
You must demonstrate your ability to understand the anatomical and physiological changes that occur for your allocated condition. This should include describing normal physiology and the changes that occur at the cellular, tissue/organ or bodily system level in relation to your allocated condition. This must be evidence based using appropriate academic sources.
Portfolio Entry 2 - Write a 2000 word report
Select one symptom, Chose Diabetic Mellitus-symptoms Polyuria.
1. Explore how this could affect your patient (500 words)
2. Evaluate 1 assessment tool (consider advantages/ disadvantages) (750 words)
3. Based on best evidence discuss the nursing management required to enable the patient to maximise their health and well-being and self-manage their condition.
This must demonstrate a holistic approach (physical, emotional, social and spiritual). You should include reference to the support of family/carers and the role of other members of the multidisciplinary team and the voluntary sector where relevant. (750 words)
Portfolio Entry 3 - In this final section, summarise the key aspects discussed in the portfolio and make recommendations on how learning may influence your future practice (approx. 500 words)
Conclusion - Key aspects discussed in the portfolio (written in the 3rd person)
Recommendations for future nursing practice (written in the 1st person)
Total 3500 words and use References APA6 style.
Some support articles -
1. AHA/NHLBI/ADA Conference Proceedings - Clinical Management of Metabolic Syndrome Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management by Scott M. Grundy, Barbara Hansen, Sidney C. Smith, James I. Cleeman, Richard A. Kahn.
2. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures by Lei Chen, Dianna J Magliano, Beverley Balkau, Stephen Colagiuri, Paul Z Zimmet, Andrew M Tonkin, Paul Mitchell, Patrick J Phillips and Jonathan E Shaw.
3. Diabetes Atlas - Global estimates of the prevalence of diabetes for 2010 and 2030 by J.E. Shaw, R.A. Sicree, P.Z. Zimmet.
4. Is diabetic dermopathy a sign for severe neuropathy in patients with diabetes mellitus? Nerve conduction studies and symptom analysis by M.E. Kiziltan, G. Benbir, M.A. Akalin.
5. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetesd 2018.
6. Pathophysiological signifcance of hepatokine overproduction in type 2 diabetes by Hirofumi Misu.
7. Screening for Type 2 Diabetes - Report of a World Health Organization and International Diabetes Federation meeting.
8. Trends in prevalence of diabetes in Asian countries by Ambady Ramachandran, Chamukuttan Snehalatha, Ananth Samith Shetty, Arun Nanditha.
9. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review Andréa D Bertoldi, Panos Kanavos, Giovanny V A França, André Carraro, Cesar Augusto Ovieda Tejada, Pedro C Hallal, Alessandra Ferrario and Maria Inês Schmidt.
10. Encouraging Physical Activity in Patients With Diabetes: Intervention Using a Reinforcement Learning System by Elad Yom-Tov, Guy Feraru, Mark Kozdoba, Shie Mannor, Moshe Tennenholtz, Irit Hochberg.
11. Pancreas Pathology During the Natural History of Type 1 Diabetes by Teresa Rodriguez-Calvo & Sarah J. Richardson & Alberto Pugliese.
12. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight by T. Drivsholm . N. de Fine Olivarius . A. B. S. Nielsen. V. Siersma.
Attachment:- Portfolio Template.rar